Cargando…
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study
No liquid biomarkers are approved in metastatic renal cell carcinoma (mRCC) despite the need to predict and monitor response noninvasively to tailor treatment choices. Urine and plasma free glycosaminoglycan profiles (GAGomes) are promising metabolic biomarkers in mRCC. The objective of this study w...
Autores principales: | Gatto, Francesco, Bratulic, Sinisa, Jonasch, Eric, Limeta, Angelo, Maccari, Francesca, Galeotti, Fabio, Volpi, Nicola, Lundstam, Sven, Nielsen, Jens, Stierner, Ulrika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309541/ https://www.ncbi.nlm.nih.gov/pubmed/36848607 http://dx.doi.org/10.1200/PO.22.00361 |
Ejemplares similares
-
Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study
por: Gatto, Francesco, et al.
Publicado: (2022) -
Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults
por: Bratulic, Sinisa, et al.
Publicado: (2022) -
Noninvasive detection of any-stage cancer using free glycosaminoglycans
por: Bratulic, Sinisa, et al.
Publicado: (2022) -
Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma
por: Gatto, Francesco, et al.
Publicado: (2018) -
Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans—A Diagnostic Prediction Model
por: D’Avanzo, Francesca, et al.
Publicado: (2023)